Global beauty trend: 'vegetarian' makeup market expands

ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
Triclosana href='https://www.echemi.com/products/pid_Seven3714-triclocarban.html'>Triclocarban.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Lessons from Disco's Demise: Navigating the Complex Terrain of Men's Skincare
-
“Milk Sugar 2.0” Cleared for Takeoff: EU Greenlights Next-Gen Human-Identical Oligosaccharide for Infant Nutrition
-
Venezuela’s Moron Petrochemical Complex Restarts as Regional Supply Risks Remain
-
Urea Market Lacks Direction as China, Iran Supply and India Tender Shape Outlook
-
India Imposes Anti-Dumping Duties on Rubber Chemicals from China, EU and U.S.
-
The Oral GLP-1 Cage Match: Orforglipron vs Rybelsus
-
Sun Pharma’s Secret Sauce: Solve the Specific, Win the Market
-
Solvay’s Zhenjiang Plant Expansion Goes Online, Doubling Electronic-Grade Hydrogen Peroxide Output to Support Semiconductor Advancements
-
Sun Pharma’s Winning Formula: Precision Over Expansion
-
Saudi Aramco’s 400,000 bpd Jazan Refinery Shuts After Attack
Recommend Reading
-
ExxonMobil “Hits the Brakes”: Industrial Fractures Under the EU’s Chemical Recycling Policy Reef
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
EU Finalizes Anti-Dumping Duties on BDO from China, with Rates up to 113.7%
-
Japan Extends Bisphenol A Anti-Dumping Probe, Prolonging Uncertainty for Korean and Taiwanese Suppliers
-
DKSH to Distribute Point Grey’s Baby and Personal Care Portfolio in Vietnam
-
Bullish and Bearish Forces Combine as Palm Oil Prices Fluctuate and Decline
-
This Week's Styrene Market Fluctuates and Declines (3.30-4.3)
-
China's Natural Rubber Market Weakens Slightly
-
BDO market trend continues to rise in China
-
Ethanol Market Prices at High Levels with Consolidation